Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Messner

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Clinical Pharmacology and Therapeutics|February 21, 2012
Current and future state of FDA-CMS parallel reviewsD A Messner, S R Tunis
The Journal of Prevention of Alzheimer'S Disease|December 21, 2018
Designing Trials of Disease Modifying Agents for Early and Preclinical Alzheimer's Disease Intervention: What Evidence is Meaningful to Patients, Providers, and Payers?D A Messner, P Rabins, A C Downing, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Clinical Pharmacology and Therapeutics|February 21, 2012
Current and future state of FDA-CMS parallel reviewsD A Messner, S R Tunis
The Journal of Prevention of Alzheimer'S Disease|December 21, 2018
Designing Trials of Disease Modifying Agents for Early and Preclinical Alzheimer's Disease Intervention: What Evidence is Meaningful to Patients, Providers, and Payers?D A Messner, P Rabins, A C Downing, et al.
Pageof 1